BRCA1 and breast cancer: It’s necessary to need large-scale researches which use uniform criterion of control groups, detection methods for methylation and sample materials, before BRCA1 promoter methylation can be a useful predictive or diagnostic biomarker for patients with breast cancer and applied to novel targeted therapeutic strategies in the future.